Cargando…
In Vivo Rodent Models of Type 2 Diabetes and Their Usefulness for Evaluating Flavonoid Bioactivity
About 40% of the world’s population is overweight or obese and exist at risk of developing type 2 diabetes mellitus (T2D). Obesity is a leading pathogenic factor for developing insulin resistance (IR). It is well established that IR and a progressive decline in functional β-cell mass are hallmarks o...
Autores principales: | Fang, Jia-You, Lin, Chih-Hung, Huang, Tse-Hung, Chuang, Shih-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470730/ https://www.ncbi.nlm.nih.gov/pubmed/30823474 http://dx.doi.org/10.3390/nu11030530 |
Ejemplares similares
-
Correction: Fang et al. In Vivo Rodent Models of Type 2 Diabetes and Their Usefulness for Evaluating Flavonoid Bioactivity. Nutrients 2019, 11, 530
por: Fang, Jia-You, et al.
Publicado: (2023) -
Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis
por: Chuang, Shih-Yi, et al.
Publicado: (2018) -
Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model
por: Yang, Shih-Chun, et al.
Publicado: (2020) -
Bioactive Flavonoid Glycosides and HPLC and UPLC Quantification of Commercial Astragali Complanati Semen
por: Kuo, Jenny Chun-Ling, et al.
Publicado: (2020) -
Natural Compounds and Aging: Between Autophagy and Inflammasome
por: Chuang, Shih-Yi, et al.
Publicado: (2014)